Form 4 for LGND LIGAND PHARMACEUTICALS INC
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0002001011-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-19 | 2025-02-14+ | LGND | Reardon Andrew | CLO, Sec | F - Tax | $120.00 | -6,523 | 29.2K | -18% | -$782.8K |
| M | 2025-02-19 | 2025-02-14 | LGND | Reardon Andrew | CLO, Sec | A - Grant | $0.00 | +12.4K | 29.5K | +72% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-14 | F | D | 1,758 | $120.00 | 30,358 | D | — | — | (F2) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of performance stock units. |
| 2 | Common | Common Stock | 2025-02-15 | F | D | 876 | $120.00 | 28,368 | D | — | — | (F3) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. |
| 3 | Common | Common Stock | 2025-02-14 | A | A | 5,429 | $0.00 | 32,116 | D | — | — | (F1) Represents shares of common stock issued upon the vesting and certification of performance stock units (PSUs). |
| 4 | Common | Common Stock | 2025-02-14 | F | D | 2,775 | $120.00 | 26,687 | D | — | — | (F2) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of performance stock units. |
| 5 | Common | Common Stock | 2025-02-14 | A | A | 6,928 | $0.00 | 29,462 | D | — | — | (F1) Represents shares of common stock issued upon the vesting and certification of performance stock units (PSUs). |
| 6 | Common | Common Stock | 2025-02-15 | F | D | 1,114 | $120.00 | 29,244 | D | — | — | (F3) Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. |